GENEVA--(BUSINESS WIRE)--Endosense, a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac arrhythmias, has been awarded ISO 13485:2003 certification for its quality management system by the certification authority NSAI. The international standard for the medical device industry, ISO 13485:2003 verifies Endosense’s ability to provide medical devices and related services that consistently meet customer needs and regulatory requirements.